Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.
JIT, M; Demarteau, N; Elbasha, E; Ginsberg, G; Kim, J; Praditsitthikorn, N; Sinanovic, E; Hutubessy, R;
2011
BMC medicine, (2011).9 1 10.1186/1741-7015-9-54.
Performance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.
LeGoff, J; Grésenguet, G; Gody, C; Longo, JD D; Khonde, N; WEISS, HA; MAYAUD, P; Bélec, L; ANRS 12-12 Study Group,;
2011
Clinical and vaccine immunology, (2011).18 7 10.1128/CVI.05003-11.
Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths.
ALEXANDER, N; CUNDILL, B; Sabatelli, L; Bethony, JM; Diemert, D; Hotez, P; SMITH, PG; RODRIGUES, LC; BROOKER, S;
2011
Vaccine, (2011).29 20 10.1016/j.vaccine.2011.03.026.
Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum.
Estévez, PT; Satoguina, J; NWAKANMA, DC; West, S; CONWAY, DJ; DRAKELEY, CJ;
2011
Malaria journal, (2011).10 1 10.1186/1475-2875-10-104.
Pneumococcal glycoconjugate vaccines produce antibody responses that strongly correlate with function.
Licciardi, PV; Balloch, A; Russell, FM; Nahm, MH; MULHOLLAND, K; Tang, ML K;
2011
Nature reviews Drug discovery, (2011).10 5 10.1038/nrd3012-c1.
T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
Ansong, D; ASANTE, KP; Vekemans, J; Owusu, SK; Owusu, R; Brobby, NA W; DOSOO, D; Osei-Akoto, A; Osei-Kwakye, K; Asafo-Adjei, E; Boahen, KO; Sylverken, J; Adjei, G; Sambian, D; Apanga, S; Kayan, K; Janssens, MH; Lievens, MJ J; Olivier, AC; Jongert, E; Dubois, P; Savarese, BM; Cohen, J; Antwi, S; GREENWOOD, BM; ... OWUSU-AGYEI, S.
2011
PloS one, (2011).6 4 10.1371/journal.pone.0018891.
Mathematical models in the evaluation of health programmes.
GARNETT, GP; COUSENS, S; Hallett, TB; Steketee, R; Walker, N;
2011
Lancet, (2011).378 9790 10.1016/S0140-6736(10)61505-X.
Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.
FLASCHE, S; VAN HOEK, AJ; Sheasby, E; Waight, P; Andrews, N; Sheppard, C; George, R; MILLER, E;
2011
PLoS medicine, (2011).8 4 10.1371/journal.pmed.1001017.
"Herd immunity": a rough guide.
FINE, P; EAMES, K; HEYMANN, DL;
2011
Clinical infectious diseases, (2011).52 7 10.1093/cid/cir007.
Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
VAN HOEK, AJ; Melegaro, A; Zagheni, E; EDMUNDS, WJ; Gay, N;
2011
Vaccine, (2011).29 13 10.1016/j.vaccine.2011.01.037.